GlobalData on MSN14h
BMS CFO backs “resilient” pharma industry amid RFK’s impending governance
Following US President-elect Donald Trump's announcement that Robert F Kennedy (RFK) Jr will be appointed as head of the ...
Business Insider23h
Truist Financial Reaffirms Their Buy Rating on Bristol-Myers Squibb (BMY)
In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Bristol-Myers Squibb (BMY – Research Report). The company’s shares closed yesterday at $56.80. Don't ...